CTOs on the Move

Activ Surgical

www.activsurgical.com

 
Activ Surgical is a digital surgery pioneer, envisioning a future of collaborative surgery, with surgical intelligence empowering scopes and robots to see what humans cannot see. The top surgeons in the world cannot be everywhere, but with Activ Surgical, their data and insights can be. Founded in 2017, Activ Surgical completed the world`s first autonomous robotic surgery of soft tissue and is building hardware-agnostic surgical software that allows surgical systems to collaborate with surgeons.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Tom Calef
Chief Technology Officer Profile

Funding

Activ Surgical raised $12.9M on 07/05/2019
Activ Surgical raised $11M on 10/29/2019
Activ Surgical raised $15M on 07/16/2020

Similar Companies

Nucleus Medical Art Inc

Nucleus Medical Art Inc is a Kennesaw, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Respicardia

Founded in 2006 and headquartered near Minneapolis, Minnesota, Respicardia® is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve Respiratory Rhythm Management and cardiovascular health. The remedē® System is an innovative implantable stimulation device designed to restore natural breathing during sleep for patients with Central Sleep Apnea.

Notal Vision

Notal Vision, makers of ForeseeHome, was founded in 2000 by ophthalmologists and medical device professionals determined to reduce vision loss associated with age-related macular degeneration (AMD).

Dynasplint Systems

Dynasplint Systems, Inc. has stepped up to sponsor the 34th annual Severna Park Independence Day Parade and Festival. Held on July 4th starting at 10:00 AM, the parade begins at St. Martin's -in-the-field and Our Shepherd Lutheran churches on Benfield

Neuromod Devices

Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation. We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control of their own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle. Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as ringing in the ears​.